The EPILOG trial. Abciximab prevents ischemic complications during angioplasty. Evaluation in PTCA to improve Long-Term Outcome with Abciximab GP IIb/IIIa Blockade.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Roe, MT; Moliterno, DJ

Published Date

  • May 1998

Published In

Volume / Issue

  • 65 / 5

Start / End Page

  • 267 - 272

PubMed ID

  • 9599910

Pubmed Central ID

  • 9599910

International Standard Serial Number (ISSN)

  • 0891-1150

Digital Object Identifier (DOI)

  • 10.3949/ccjm.65.5.267

Language

  • eng

Conference Location

  • United States